Nath Bio-Genes (India) profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 6.3% | 6.3% | 6.2% | 6.7% | 6.3% | ||
| 3.9% | 3.9% | 4.1% | 4.7% | 4.6% | ||
| 7.1% | 7.1% | 7.2% | 7.8% | 7.9% | ||
| 5.4% | 5.9% | 6.5% | 7.0% | 6.9% | ||
Margins | ||||||
| 10.1% | 11.8% | 13.7% | 15.0% | 16.2% | ||
| 10.9% | 10.9% | 12.6% | 14.0% | 15.2% | ||
| — | 3.1% | −1.9% | 2.8% | — | ||
| 8.9% | 10.4% | 11.1% | 12.5% | 12.0% | ||
| 7.5% | 9.4% | 10.6% | 11.9% | 11.6% | ||
| — | — | 10.6% | 11.9% | — | ||
| −3.5% | −3.5% | 2.7% | 18.6% | 11.9% | ||
Additional | ||||||
| 10.9% | 10.1% | 4.9% | 4.7% | 3.2% | ||
| — | 9.1% | 9.8% | 9.6% | 10.9% | ||
| 6.3% | 5.7% | 5.5% | 6.1% | 5.6% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.